Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

EU regulators fine Johnson & Johnson, Novartis AG 16 mln euros for generic drug deal - Reuters

Tuesday, 10 Dec 2013 09:00am EST 

Johnson & Johnson and Novartis AG:European Union antitrust regulators fined Johnson & Johnson .N and Novartis AG a total of 16 million euros ($21.95 million) on Dec. 10 for blocking the sale of a generic painkiller in the Dutch market - Reuters.The European Commission said in a statement that the deal between the two companies meant patients did not have access to the cheaper generic version of fentanyl for 17 months starting from July 2005.Johnson & Johnson and its Dutch unit, Janssen-Cilag, were fined 10.8 million euros while Novartis and its Dutch subsidiary, Sandoz, were fined 5.5 million euros. 

Company Quote

0.93 +0.94%
1 May 2015